PREDICTIVE FACTORS FOR TREATMENT FAILURE IN AML PATIENTS RECEIVING VENETOCLAX COMBINED WITH AZACITIDINE: A REAL-WORLD RETROSPECTIVE STUDY

EHA Library, Zi-Yuan Nie, 4161619

Azacitidine Combined with Intermediate-dose Cytarabine Consolidation in Newly Diagnosed Acute Myeloid Leukemia

EHA Library, Qiuling Wu, 4161620

LOW-DOSE CHEMOTHERAPY FOR INDUCTION REMISSION IN CHINESE CHILDHOOD WITH M2 SUBTYPE OF ACUTE MYELOID LEUKEMIA: A MULTICOHORT, RANDOMIZED PHASE 3 TRIAL

EHA Library, Wenxin Ou, 4161621

IMPACT OF FLT3 MUTATIONS ON DIC PRESENTATION IN DE NOVO AND SECONDARY ACUTE MYELOID LEUKEMIA

EHA Library, Maria Bacanu, 4161622

EFFICACY AND SAFETY OF GILTERITINIB IN R/R FLT3 ACUTE MYELOID LEUKEMIA: A REAL-WORLD STUDY

EHA Library, Ana Maria Hoyos Brea, 4161623

FLOW CYTOMETRIC EVALUATION OF CD110 IS A NOVEL AND SPECIFIC MARKER FOR DIAGNOSIS OF ACUTE MEGAKARYOBLASTIC LEUKEMIA

EHA Library, Hui Wang, 4161624

REAL-WORLD SURVIVAL OF IDH-MUTANT PATIENTS IN CHINA BEFORE IDH-INHIBITOR ERA

EHA Library, Zihan Chen, 4161625

RISK FACTORS AND CLINICAL OUTCOMES OF CANDIDA TROPICALIS VERSUS NON-TROPICALIS CANDIDEMIA IN PATIENTS WITH HEMATOLOGICAL DISORDER

EHA Library, Zhangjie Chen, 4161626

SECONDARY ACUTE ERYTHROID LEUKEMIA: A RARE ENTITY

EHA Library, Angeliki Kotsiafti, 4161627

TRIAL IN PROGRESS: A PHASE 2 STUDY OF AZACITIDINE AND VENETOCLAX FOR ACUTE MYELOID LEUKEMIA WITH MEASURABLE RESIDUAL DISEASE BEFORE ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION?

EHA Library, Meira Yisraeli Salman, 4161628

IDENTICAL T(11;12)(P15;Q13) CHROMOSOMAL TRANSLOCATION WITH DISTINCT NUP98::RARG AND NUP98::HOXC13 FUSION GENES IN RARE SUBTYPES OF ACUTE MYELOID LEUKEMIA: THE SIGNIFICANCE OF PRECISE DIAGNOSIS

EHA Library, Tong Wang, 4161629

THE CLINICOPATHOLOGIC SIGNIFICANCE OF MATRIX METALLOPROTEINASE 1 GENE EXPRESSION IN ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Naima Abdullahi, 4161630

RAPHAEL: A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY TO EVALUATE HMPL-306 (RANOSIDENIB) IN PATIENTS (PTS) WITH IDH1- AND/OR IDH2-MUTATED RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Lijuan Hu, 4161631

OUTCOME PREDICTION FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES

EHA Library, Sviatlana Haurylava, 4161632

REAL-WORLD OUTCOMES OF ORAL AZACITIDINE BASED MAINTENANCE THERAPY FOR ACUTE MYELOID LEUKEMIA IN REMISSION: A SINGLE CENTRE EXPERIENCE IN INDIAN POPULATION

EHA Library, Akshay Middinti, 4161633

OPTIMAL TIMING OF MULTICOLOR FLOW CYTOMETRY AND MOLECULAR MEASURABLE RESIDUAL DISEASE ASSESSMENT FOR PREDICTING ACUTE MYELOID LEUKEMIA RELAPSE AND SURVIVAL: A SINGLE-CENTER EXPERIENCE

EHA Library, Alexander Li, 4161634

LOWER-INTENSITY CHEMO-IMMUNOTHERAPY WITH CLADRIBINE, LOW-DOSE CYTARABINE, VENETOCLAX AND BLINATUMOMAB PRODUCES HIGH RESPONSE RATES IN PATIENTS WITH BCR::ABL1-NEGATIVE B/MYELOID MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL)

EHA Library, Tapan Kadia, 4161635

OUTCOMES OF RECENT NOVEL THERAPEUTIC AGENTS IN TP53-MUTATED ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME IN THE FRONTLINE SETTING

EHA Library, Zaker Schwabkey, 4161636

SELINEXOR-BASED NON-INTENSIVE CHEMOTHERAPY REGIMENS ADJUSTED ACCORDING TO EARLY RESPONSES ACHIEVE HIGH EARLY REMISSION IN NEWLY DIAGNOSED AML OR MDS

EHA Library, Shiyuan Zhang, 4161637

ACUTE MYELOID LEUKEMIA WITH T(11;20)/NUP98::TOP1

EHA Library, Shaobin Yang, 4161638

VENETOCLAX-BASED REGIMENS AS FIRST-LINE TREATMENT IN ADULT PATIENTS WITH NEWLY DIAGNOSED POOR-RISK CYTOGENETIC RISK AML. SINGLE CENTER EXPERIENCE

EHA Library, Nikita Pastukhov, 4161639

A PHASE 1 OPEN-LABEL TRIAL OF LAVA-1266, A CD123-TARGETING BISPECIFIC Vγ9VΔ2-T CELL ENGAGER, IN PATIENTS WITH CD123 POSITIVE RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) AND INTERMEDIATE TO EXTREMELY HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS)

EHA Library, Shaun Fleming, 4161640

DIAGNOSIS AND TREATMENT OF ACUTE ERYTHROID LEUKAEMIA

EHA Library, Zois Mellios, 4161641

VENETOCLAX COMBINED WITH IDAUNORUBICIN AND CYTARABINE(2+3) AS INDUCTION TREATMENT IN ADULTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, xuexing Chen, 4161642

CLINICAL IMPACT OF DNMT3A, TET2 AND ASXL1 MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Anastasiia Kashlakova, 4161643

FINITE-DURATION VENETOCLAX-AZACITIDINE PLUS DECITABINE PRIMING WITH CYTARABINE FOLLOWED BY UMBILICAL CORD BLOOD INFUSION IMPROVES SURVIVAL IN UNFIT ELDERLY PATIENTS WITH UNTREATED AML: A RETROSPECTIVE ANALYSIS

EHA Library, Li Ye, 4161644

NK-CELLS INFUSIONS TO PREVENT RELAPSE AND REDUCE TOXICITY IN STANDART RISK AML

EHA Library, Maryia Navumovich, 4161645

EFFECT OF CYTOREDUCTIVE CHEMOTHERAPY ON THE INCIDENCE OF DIFFERENTIATION SYNDROME IN PATIENTS WITH NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Zhiling Yan, 4161646

REGISTRATIONAL PHASE 3 STUDY OF ZIFTOMENIB IN COMBINATION WITH NON-INTENSIVE OR INTENSIVE CHEMOTHERAPY FOR NEWLY DIAGNOSED NPM1-M AND/OR KMT2A-R ACUTE MYELOID LEUKEMIA (AML): THE KOMET-017 TRIAL

EHA Library, Amer M. Zeidan, 4161647

AGE-RELATED DISPARITIES IN ACUTE MYELOID LEUKEMIA: A SINGLE-CENTER COMPARATIVE ANALYSIS OF CLINICAL CHARACTERISTICS AND OUTCOMES IN ADOLESCENTS/YOUNG ADULTS VERSUS OLDER ADULTS

EHA Library, Omar Shahin, 4161648

THE ROLE OF INTERIM BONE MARROW ASSESSMENTS IN ACUTE MYELOID LEUKEMIA - A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Yuanli Lei, 4161649

A PHASE 1 STUDY OF REVUMENIB + INTENSIVE CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA HARBORING GENETIC ALTERATIONS IN KMT2A, NPM1, OR NUP98 (SNDX-5613-0708)

EHA Library, Ibrahim Aldoss, 4161650

CHARACTERISTICS AND TREATMENT PATTERNS OF ADULTS RELAPSING FROM ACUTE MYELOID LEUKEMIA

EHA Library, Youssra Fakhfakh, 4161651

PHASE 1 STUDY OF MITOTIC CHECKPOINT INHIBITOR BAL0891 AS MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Eric Feldman, 4161652

DECODING ACUTE MYELOID LEUKEMIA: UNRAVELLING THE LINK BETWEEN IMMUNOPHENOTYPIC MARKERS AND GENETIC ALTERATIONS

EHA Library, Aastha Gupta, 4161653

QUANTUM-WILD: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF QUIZARTINIB IN COMBINATION WITH CHEMOTHERAPY AND AS SINGLE-AGENT MAINTENANCE IN FLT3-ITD-NEGATIVE ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Pau Montesinos, 4161654

CURRENT TREATMENT LANDSCAPE OF NEWLY DIAGNOSED IDH1-MUTANT ACUTE MYELOID LEUKEMIA PATIENTS IN CHINA: INSIGHTS FROM A SINGLE-CENTER RETROSPECTIVE ANALYSIS

EHA Library, Xiaoqing Li, 4161655

EARLY REPLACEMENT OF REINDUCTION THERAPY FOLLOWING FAILED INTENSIVE INDUCTION TREATMENT ENHANCES THE THERAPEUTIC EFFICACY OF NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Jingchen Sui, 4161656

MEASURABLE RESIDUAL DISEASE AS PROGNOSTIC AND PREDICTIVE TOOL IN ACUTE MYELOBLASTIC LEUKEMIA- OUTCOME SINGLE CENTER EXPIRIANCE

EHA Library, Violeta Milosevic, 4161657

EFFICACY AND OUTCOMES OF NOVEL THERAPEUTIC AGENTS AS MONOTHERAPY OR IN COMBINATION WITH CONVENTIONAL THERAPY IN ACUTE MYELOID LEUKEMIA: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Moazzam Shahzad, 4161658

OUTCOME OF CORE BINDING FACTOR ACUTE MYELOID LEUKAEMIA: A RETROSPECTIVE REVIEW IN A MALAYSIA TERTIARY CENTRE

EHA Library, Kee Tat Lee, 4161659

CLINICAL OUTCOMES AND SURVIVAL IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA IN A REAL-WORLD SETTING

EHA Library, Claudia Sossa-Melo, 4161660

AZACITIDINE AND VENETOCLAX COMBINATION IN NEWLY DIAGNOSED ACUTE MYELOID LEUKAEMIA: A TERTIARY CARE CENTRE EXPERIENCE

EHA Library, Naveenvairamoorthy Dakshinamoorthy, 4161661

THE CRITICAL ROLE OF FLOW CYTOMETRY IN THE DIAGNOSIS OF A BPDCN

EHA Library, Evan Calliauw, 4161662

EXCLUSIVE EXTRAMEDULLARY PRIMARY MYELOID SARCOMA IN SMALL INTESTINE AS THE CAUSE OF AN ACUTE BOWEL OBSTRUCTION: CASE REPORT AND LITERATURE REVIEW.

EHA Library, Arthur Gomes Oliveira Braga, 4161663

A RANDOMIZED, OPEN LABEL, SINGLE-DOSE, 4-PERIOD, 4-TREATMENT CROSS-OVER STUDY TO EVALUATE THE PHARMACOKINETICS OF ORAL ARSENIC TRIOXIDE SOLUTION (SDK001) AND TO COMPARE TO INTRAVENOUS ARSENIC TRIOXIDE

EHA Library, Harinder Gill, 4161664

THERAPY, RISK FACTORS AND OUTCOMES OF PATIENTS WITH RELAPSED ACUTE MYELOBLASTIC LEUKEMIA - EXPERIENCE OF A SINGLE CENTER

EHA Library, Jovan Rajic, 4161665

UNVEILING THE RARE T(16;21)/RUNX1::RUNX1T3 FUSION: CLINICAL INSIGHTS AND PROGNOSTIC IMPLICATIONS

EHA Library, Cui Wang, 4161666

CHARACTERIZATION OF GENE MUTATION DISTRIBUTION AND PROGNOSTIC IMPACT IN PATIENTS WITH ACUTE MYELOID LEUKEMIA BASED ON SECOND-GENERATION SEQUENCING TECHNOLOGY

EHA Library, Tao Wu, 4161667

THE SAFETY AND EFFICACY OF SONROTOCLAX COMBINED WITH AZACITIDINE (AZA) AND HAG IN PATIENTS (PTS) WITH REFRACTORY/ RELAPSED (R/R) ACUTE MYELOID LEUKEMIA (AML): A PHASE II STUDY

EHA Library, Qingsong Yin, 4161668

CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES OF TREATMENT-NAÏVE IDH-MUTATED AML PATIENTS IN THE PRE-IDH INHIBITOR ERA

EHA Library, Yanping Yang, 4161669

A PROSPECTIVE STUDY OF VAH(VENETOCLAX,AZACITIDINE AND HOMOHARRINGTONINE) REGIMEN IN NEWLY DIAGNOSED FIT ELDERLY AML PATIENTS

EHA Library, Deng Pan, 4161670

REAL WORLD EXPERIENCE OF BONE MARROW FLOW MRD MONITORING IN AML PATIENTS RECEIVING VENETOCLAX AND AZACYTIDINE AS FIRST LINE TREATMENT - SINGLE CENTRE STUDY

EHA Library, Vidhya Murthy, 4161671

OPTIMIZATION OF THERAPY FOR ACUTE MYELOID LEUKEMIA IN ELDERLY PATIENTS WITHIN THE URBAN HEALTHCARE SYSTEM: RESULTS OF OUR OWN EXPERIENCE

EHA Library, Tatyana Tolstykh, 4161672

CLINICAL AND EPIDEMIOLOGICAL ASPECTS OF ACUTE MYELOBLASTIC LEUKEMIA IN ADULTS: A STUDY FROM SFAX'S HEMATOLOGY DEPARTMENT

EHA Library, Nour Siala, 4161673

RECENT DISCOVERIES REGARDING THE GENETIC LANDSCAPE OF ACUTE MYELOID LEUKEMIA WITH MUTATED NPM1 GENE

EHA Library, Ekaterina Motyko, 4161674

INFECTIOUS COMPLICATIONS DURING INDUCTION CHEMOTHERAPY IN YOUNG ADULTS WITH ACUTE MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS OF CLINICAL OUTCOMES AND THERAPEUTIC STRATEGIES

EHA Library, Kmar Mrad, 4161675

PROGNOSTIC ROLE OF CD36 IN ACUTE MYELOID LEUKEMIA: INSIGHTS INTO SURVIVAL, FEBRILE NEUTROPENIA, AND CARDIOVASCULAR DISEASE ASSOCIATIONS

EHA Library, Ahmet Yigitbasi, 4161676

ERDHEIM-CHESTER DISEASE IN A 28-YEAR-OLD FEMALE MANAGED WITH VINBLASTINE-PREDNISONE PROTOCOL, A CASE REPORT

EHA Library, Richielyn Mae Miñon, 4161677

ACUTE MYELOID LEUKEMIA IN YOUNG ADULTS: CLINICAL FEATURES, TREATMENT STRATEGIES, AND OUTCOMES IN A MONOCENTRIC STUDY FROM TUNISIA

EHA Library, Kmar Mrad, 4161678

VENETOCLAX IN THE TREATMENT OF RELAPSED OR REFRACTORY PEDIATRIC ACUTE MYELOID LEUKEMIA: A GLIMMER OF HOPE IN A CHALLENGING THERAPEUTIC CONTEXT

EHA Library, Cyrine Michani, 4161679

INDIVIDUALIZED AND INCLUSIVE STRATEGIES FOR TREATING JEHOVAH'S WITNESSES WITH ACUTE LEUKEMIA AND HIGH-GRADE MYELOID NEOPLASMS

EHA Library, Jabra Zarka, 4161680

FLOW CYTOMETRIC PROFILING OF MEASURABLE RESIDUAL DISEASE (MRD) IN AML PATIENTS: IMPACT ON RELAPSE-FREE SURVIVAL POST-HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) - AN EXPERIENCE FROM A SINGLE TERTIARY CARE CENTER IN INDIA

EHA Library, Aastha Gupta, 4161681

EARLY MORTALITY IN PEDIATRIC ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, chatti sirine, 4161682

GRANULOCYTIC SARCOMA: CLINICAL AND PATHOLOGICAL ANALYSIS OF 12 CASES

EHA Library, Nour Siala, 4161683

CLINICAL PROFILE & TREATMENT RESULTS OF PAEDIATRIC ACUTE MYELOID LEUKEMIA PATIENTS: A SINGLE-CENTER EXPERIENCE FROM AIIMS RISHIKESH INDIA

EHA Library, Arjun Kachhwaha, 4161684

PRELIMINARY CLINICAL EFFICACY OF AZACITIDINE COMBINED WITH LOW-DOSE CYTARABINE AND SHORT-TERM VENETOCLAX FOR NEWLY DIAGNOSED ELDERLY/FRAIL ACUTE MYELOID LEUKEMIA

EHA Library, Yi Wang, 4161685

THE DNA-PK INHIBITOR, M3814 (PEPOSERTIB), IS CYTOTOXIC TO CHRONIC LYMPHOCYTIC LEUKEMIA CELLS EX VIVO AND SYNERGISTIC WITH VENETOCLAX

EHA Library, Clare Hibbert, 4161686

ELEVATED TRANSCRIPTIONAL ACTIVITY OF TRANSPOSABLE ELEMENTS AS A MARKER OF AGGRESSIVENESS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Heiko Müller, 4161687

A PECULIAR LNCRNA SIGNATURE CHARACTERIZES SYMPTOMATIC T-LARGE GRANULAR LYMPHOCYTE LEUKEMIA (T-LGLL) PATIENTS

EHA Library, Elena Buson, 4161688

MOLECULAR CHARACTERISATION OF CLL PATIENTS RESISTANT TO TARGETED THERAPY USING CCLL, A COMPREHENSIVE NGS-BASED APPROACH

EHA Library, Tamás László, 4161690

THE POTENTIAL ROLE OF MIR-29C-3P IN REGULATING TNF SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Mischa Vervoordeldonk, 4161691

NGS-BASED MOLECULAR ANALYSIS OF CLL: COMPARISON OF NGS AT THE MOMENT OF DIAGNOSIS VS. BEFORE TREATMENT IN A MULTICENTER STUDY.

EHA Library, Amagoia Ruiz Martin, 4161692

CDC1-BASED VACCINES HAVE THE POTENTIAL TO ENHANCE T LYMPHOCYTE RESPONSE AGAINST TUMOR CELLS IN CHRONIC LYMPHOCYTIC LEUKAEMIA AND RICHTER SYNDROME

EHA Library, Carola Di Camillo, 4161693

IMMUNOPHENOTYPIC ANALYSIS OF T CELLS IN TREATMENT NAÏVE CLL PATIENTS.

EHA Library, Agni Vitsioti, 4161694

AN ASSESSMENT OF THE NKG2D RECEPTOR IN CLL PATIENTS

EHA Library, Islam Abdelkader, 4161695

ROLE OF STRENGTH-BASED EXERCISE TRAINING IN RISK AND SURVIVAL OUTCOMES FOR CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS.

EHA Library, Pedro Cunha, 4161696

CHARACTERISTICS OF ARMENIAN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS DIAGNOSED FROM 2019-2023

EHA Library, Gevorg Saghumyan, 4161697

CLINICAL EFFICACY AND TOLERABILITY OF VENETOCLAX PLUS RITUXIMAB IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA - REAL-WORLD ANALYSIS OF POLISH ADULT LEUKEMIA STUDY GROUP

EHA Library, Anita Soboń, 4161698

A REAL-WORLD COMPARISON OF HYPERTENSION AND CARDIOVASCULAR ADVERSE EVENTS WITH ACALABRUTINIB VS IBRUTINIB IN PATIENTS WITH TREATMENT-NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA

EHA Library, George Dranitsaris, 4161700

THE DIAGNOSTIC PATHWAY AND ACTIVE MONITORING EXPERIENCE FOR PEOPLE WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND CONTRASTS WITH OTHER TYPES OF LEUKAEMIA: FINDINGS FROM A GLOBAL SURVEY.

EHA Library, Nick York, 4161701

CHRONIC LYMPHOCYTIC LEUKEMIA AND ASSOCIATED CHRONIC LUNG DISEASES: PREVALENCE AND CLINICAL IMPACT

EHA Library, Tamar Tadmor, 4161702

REAL-WORLD EFFECTIVENESS AND TOLERABILITY OF VENETOCLAX-BASED TREATMENT IN OCTOGENARIAN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Liron Hofstetter, 4161703

EVALUATING UPTAKE OF TARGETED AGENTS BY RACE/ETHNICITY IN PATIENTS RECEIVING FIRST-LINE TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Adam S. Kittai, 4161704

FINAL INDEPENDENT REVIEW DATA SUPPORTS SUSTAINED BENEFIT OF ZANUBRUTINIB OVER IBRUTINIB IN PATIENTS WITH R/R CLL/SLL IN ALPINE

EHA Library, Jennifer R. Brown, 4161705

AN ONGOING PHASE 1B TRIAL EVALUATING MOSUNETUZUMAB MONOTHERAPY AND A COMBINED REGIMEN OF MOSUNETUZUMAB AND VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Paula Marlton, 4161706

A REAL-WORLD MULTICENTER ANALYSIS OF FRONT-LINE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Arthur Coste, 4161707

COST-EFFECTIVENESS OF VENETOCLAX-OBINUTUZUMAB VS. VENETOCLAX-RITUXIMAB, VENETOCLAX-OBINUTUZUMAB-IBRUTINIB, AND CHEMOIMMUNOTHERAPY IN TREATMENT-NAÏVE FIT CLL PATIENTS WITHOUT TP53 ABERRATIONS

EHA Library, Lars Ehlers, 4161708

EPIDEMIOLOGY AND CLINICAL CHARACTERISTICS OF RICHTER TRANSFORMATION: A SINGLE CENTER EXPERIENCE OF THE LAST 20 YEARS

EHA Library, Ester Lovato, 4161709

CLL18/MOIRAI INTERNATIONAL PHASE-III TRIAL: AIMING TO ESTABLISH MEASUREMENT OF INDIVIDUAL RESIDUAL DISEASE FOR ADJUSTMENT OF TREATMENT DURATION TO IMPROVE OUTCOMES IN FIRSTLINE TREATMENT OF CLL/SLL

EHA Library, Paula Cramer, 4161710

INFECTIONS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH VENETOCLAX-BASED REGIMENS: A REAL-WORLD ANALYSIS OF POLISH ADULT LEUKEMIA GROUP (PALG)

EHA Library, Elżbieta Kalicińska, 4161711

OPTIMIZING MARKERS FOR CHRONIC LYMPHOCYTIC LEUKEMIA DIAGNOSIS BY FLOW CYTOMETRY: RESULTS FROM THE NATIONWIDE THAI LYMPHOMA STUDY GROUP

EHA Library, Ornnicha Sathitakorn, 4161712

WHEN THE SECOND IS FASTER THAN THE FIRST ONE: LYMPHOCYTOSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA IS SHORTER WITH SECOND GENERATION BTKI. AN ITALIAN EXPERIENCE.

EHA Library, Luca Laurenti, 4161713

EFFICACY OF CONTINUOUS ZANUBRUTINIB VS FIXED-DURATION VENETOCLAX IN COMBINATION WITH OBINUTUZUMAB IN TREATMENT-NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA: A MATCHING-ADJUSTED INDIRECT COMPARISON

EHA Library, Talha Munir, 4161714

COMPARATIVE EFFICACY OF IBRUTINIB VERSUS OTHER COVALENT BRUTON TYROSINE KINASE INHIBITORS (CBTKIS) IN FIRST-LINE (1L) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A MATCHED-ADJUSTED INDIRECT COMPARISON (MAIC).

EHA Library, Alexey Danilov, 4161715

PIRTOBRUTINIB AFTER A COVALENT BTK INHIBITOR IN PRETREATED CHRONIC LYMPHOCYTIC LEUKEMIA: A PHASE 2 DOSE OPTIMIZATION TRIAL IN PROGRESS

EHA Library, Alexey Danilov, 4161716

A SYSTEMATIC REVIEW AND METANALYSIS OF FIRST LINE THERAPY WITH IBRUTINIB PLUS VENETOCLAX IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Andrea Visentin, 4161717

PREFERENCES FOR TREATMENT IN FIRST-LINE CHRONIC LYMPHOCYTIC LEUKEMIA: A MULTI-CRITERIA DECISION ANALYSIS IN ITALY

EHA Library, Paolo Sportoletti, 4161718

REAL-WORLD EVIDENCE OF CHRONIC LYMPHOCYTIC LEUKAEMIA IN COLOMBIA: FIRST REPORT FROM THE RENEHOC REGISTRY

EHA Library, Virginia Abello Polo, 4161719

A COMPREHENSIVE ANALYSIS OF PATIENT CHARACTERISTICS AND REAL-WORLD EXPERIENCE IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WITH OVER 10 YEARS OF FOLLOW-UP.

EHA Library, Karthik Jayalingappa, 4161720